Profile data is unavailable for this security.
About the company
Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest Inc., which is a biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest Inc.’s technology platform includes a panel of tumor antigen specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent, which is developing antibody-based immunotherapeutic products for cancer in the Greater China territory.
- Revenue in CAD (TTM)0.00
- Net income in CAD13.44m
- Incorporated1996
- Employees0.00
- LocationQuest Pharmatech Inc8123 Roper Rd NWEDMONTON T6E 6S4CanadaCAN
- Phone+1 (780) 448-1400
- Fax+1 (780) 448-1400
- Websitehttp://www.questpharmatech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intellipharmaceutics International Inc | 1.24m | -4.35m | 2.65m | 33.00 | -- | -- | -- | 2.14 | -0.1313 | -0.1313 | 0.0374 | -0.5327 | 0.6027 | -- | 3.37 | -- | -211.39 | -132.15 | -- | -- | -88.96 | -- | -350.72 | -499.37 | -- | -19.36 | -- | -- | -- | -58.75 | 43.78 | -- | -- | -- |
Radient Technologies Inc | 3.15m | -11.30m | 2.70m | 33.00 | -- | -- | -- | 0.859 | -0.0216 | -0.0216 | 0.006 | -0.0278 | 0.1108 | 1.56 | 6.00 | -- | -39.76 | -67.36 | -- | -118.27 | -3.91 | 1.66 | -359.00 | -534.11 | 0.0251 | -3.58 | -- | -- | 45.49 | 65.30 | 69.41 | -- | 200.33 | -- |
Aequus Pharmaceuticals Inc | 215.21k | -2.88m | 3.32m | 12.00 | -- | -- | -- | 15.41 | -0.0217 | -0.0217 | 0.0016 | -0.0373 | 0.2094 | 1.23 | 11.31 | -- | -280.53 | -97.96 | -- | -293.31 | 58.26 | -- | -1,339.39 | -141.53 | 0.0724 | -16.30 | 7.83 | -- | -81.53 | -28.97 | 7.64 | -- | -- | -- |
Quest PharmaTech Inc | 0.00 | 13.44m | 3.38m | 0.00 | 0.2516 | 0.1461 | 0.2516 | -- | 0.0795 | 0.0795 | 0.00 | 0.1369 | 0.00 | -- | -- | -- | 52.43 | 7.62 | 55.03 | 8.45 | -- | -- | -- | -- | -- | -- | 0.0414 | 0.00 | -- | -- | 95.35 | -- | -- | -- |
Genix Pharmaceuticals Corp | 10.83k | -4.23m | 3.55m | -- | -- | -- | -- | 328.11 | -0.0714 | -0.0714 | 0.0002 | -0.0202 | 0.0049 | 0.0502 | 1.89 | -- | -191.99 | -54.69 | -476.20 | -68.59 | 23.08 | -- | -39,036.01 | -5,345.88 | 0.0541 | -10.33 | -- | -- | -- | -50.60 | -309.27 | -- | -- | -- |
Eve & Co Inc | 7.77m | -5.92m | 3.76m | -- | -- | -- | -- | 0.4843 | -0.2055 | -0.2055 | 0.2698 | 0.733 | 0.1519 | 0.7493 | 8.73 | -- | -11.58 | -- | -24.24 | -- | -3.10 | -- | -76.22 | -- | 0.062 | -5.05 | 0.4892 | -- | 2.94 | -- | -71.97 | -- | -- | -- |
Marvel Biosciences Corp | 0.00 | -2.51m | 4.18m | -- | -- | -- | -- | -- | -0.0632 | -0.0632 | 0.00 | -0.0617 | 0.00 | -- | -- | -- | -372.25 | -- | -- | -- | -- | -- | -- | -- | -- | -26.43 | -- | -- | -- | -- | 10.29 | -- | -- | -- |